The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Open accessAbstract
Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case–control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TADA requires a mutational model (Sanders et al., 2012; Neale et al., 2012; Samocha et al., 2014) which accounts for gene size and sequence composition to obtain an expectation for mutations per gene, given sample size.”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Neale et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exome sequencing of ASD/ID families has revealed a significant excess of de novo mutations in probands when compared to unaffected siblings and has identified novel candidate genes contributing to the neurological deficits.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We note that the strongest effects are observed for de novo loss-of-function (or truncating) mutations”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Simulations based on the observed number of recurrently disrupted genes have estimated that there are some 600-1200 ASD risk genes (21,24,26,51).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mutations in chromatin complexes have been observed in schizophrenia where synaptic gene regulation is disrupted, and these mutations are also high-confidence genetic risk factors for ASD”
From The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry (2025) · cites this paper as [42]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“These studies demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Many strong neurobiological candidates have emerged from the genes disrupted by de novo mutations in these studies, including mutations in previously identified ASD/ID genes.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One of the INH-M13 hub genes is CHD2, whose de novo variants have been identified in individuals with ASD.42,43”
From hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data (2023) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One of the INH-M13 hub genes is CHD2, whose de novo variants have been identified in individuals with ASD.42,43”
From hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data (2023) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“CNVs and SNPs have both been reported to play a major role in autism incidence (36–41).”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [38]
In the citing paper
“These estimates are similar to published results using somewhat different methods [1], [2].”
From Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes (2013) · cites this paper as [2]
In the citing paper
“Exome sequencing has uncovered de novo single nucleotide variations (SNVs) and insertion/deletion (indel) mutations that segregate with ASD.”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Neale et al., 2012
In the citing paper
“Hypomorphic, biallelic mutations, combined with CNVs and heterozygous stop mutations (Neale et al., 2012; O’Roak et al., 2012; Sanders et al., 2012) which completely inactivate one of two alleles, suggest that a common theme for ASD mutations in general might be partial loss of gene function and/or dosage sensitivity.”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Neale et al., 2012
In the citing paper
“ASD is often due to newly arising gene copy number variants (CNVs) — such as a deletion or duplication of a region of a chromosome — or a rare mutation that arises in the germ cell, particularly in sperm of older fathers5–10.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
In the citing paper
“In addition, very recent exome sequencing of parent-offspring trios has identified de novo exonic mutations in SCN2A, KATNAL2, CHD8, FOXP1, NTNG1, GRIN2B, LAMC3(refs 7–9), extending further the number of genes for which mutation may contribute to ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
In the citing paper
“References 7– 10 use exome and entire genome sequencing to demonstrate the importance of rare mutations in ASD and identify new genetic mutations associated with ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
In the citing paper
“and also that the loci hit by these SNVs are highly heterogeneous”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [48]
In the citing paper
“Together, results from these papers demonstrate a significant role for rare SNVs in genetic liability for ASD”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [48]
In the citing paper
“finding a handful of genes that are recurrently hit by these rare variants”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [48]
In the citing paper
“Exome and whole-genome sequencing studies have estimated at least another ∼6% contribution to ASD7–10,15”
From Convergence of genes and cellular pathways dysregulated in autism spectrum disorders (2014) · cites this paper as [8]
In the citing paper
“De novo SNVs in CHD2 have been reported in an ASD subject and in several individuals with a broad spectrum of neurodevelopmental disorders, including ID and epileptic encephalopathy8,49,50 (Figure S6).”
From Convergence of genes and cellular pathways dysregulated in autism spectrum disorders (2014) · cites this paper as [8]
In the citing paper
“and three other recent studies by Sanders et al.8, O’Roak et al.7 and Neale et al.23 (65 genes combined from all three; referred to as ‘SON-exomes’);”
From Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism (2014) · cites this paper as [23]
In the citing paper
“Genetic investigations in ASD have constructed seed-based networks with literature-curated PPIs to identify the convergence of ASD risk genes71,73.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [73]
In the citing paper
“In summary, only three genes [CHD8, SCN2A, and synaptic Ras GTPase activating protein 1 (SYNGAP1)] had two independent truncating de novo mutations in any single study, and no gene had more than three mutations.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“Notably, however, a follow-up case-control study by Neale and colleagues of 935 cases found three additional truncating CHD8 mutations and one splice-site mutation in SCN2A, further strengthening the initial disease associations of these genes [25].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“New exome sequencing technology has identified novel rare variants and has found that sporadic cases of ASD/ID are enriched for disruptive de novo mutations.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“To date, in addition to causal and highly penetrant genes and genomic loci identified before whole-exome sequencing (15,30), over 50 high-risk genes have emerged from the large-scale sequencing studies (21)(22)(23)(24)(25)(26), most under a model of autosomal dominant variation.”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Rare genetic risk variation identified to date, in contrast, has a very substantial effect on individual risk.Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“At this point, it is clear that rare microscopically detectable chromosomal rearrangements (14,15), submicroscopic deletions or duplications (CNV or smaller structural variation) (27,(29)(30)(31)(32), single-nucleotide variation (SNV) and small deletions and duplications (indels) (21)(22)(23)(24)(25)(26)(33)(34)(35) all contribute to risk.”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations that were previously identifiable only by traditional genetic approaches and targeted sequencing (14,15).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“TBR1 has been implicated in ASD (21,22,25,26) and ID (73).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Qualitatively, recent studies of rare variants also find it challenging to distinguish risk variation from the background stochastic noise (12–15).”
From Individual common variants exert weak effects on the risk for autism spectrum disorders (2012) · cites this paper as [14]
In the citing paper
“Albeit rare, de novo mutations have emerged as substantial contributors to ASD risk [83, 165, 166, 254, 261, 309].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [254]
In the citing paper
“Recent exome sequencing studies only reported one de novo SHANK2 mutation out of 965 patients [32], [36], [37]”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [37]
In the citing paper
“no truncating coding-sequence variation within SHANK1 and SHANK3”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [37]
In the citing paper
“However, a central finding from these papers was that only a minority of cases had a de novo putatively functional variant”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Three recent papers describe the results from exome sequencing of ~600 trios, and identify roles for de novo exonic mutations in SCN2A, KATNAL2, and CHD8 in the pathogenesis of ASD. 83–85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Intriguingly, all three studies noted an increased rate of de novo exonic mutations in older parents (with the mutations generally being of paternal origin), 83–85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Unexpectedly, simplex and multiplex ASD pedigrees show relatively similar de novo mutation rates for SV 80,81 and exonic variation. 83–85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“pathway analyses reported in two of the studies found that genes containing de novo exonic variation were more closely connected in reference to protein-protein interaction databases. 83,84”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“estimates from de novo exonic mutations (similar to those from SV data) suggest that ASD is highly polygenic (estimates ranged from 400–1000 genes). 84,85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“The published results for ASD 83–85 and unpublished data on SCZ suggest these issues will be important and underscore the need for sequencing studies to have the same emphasis on statistical rigor and large sample sizes that has enabled GWAS to realize success for multiple psychiatric disorders. 154”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Many studies of complex neuropsychiatric disorders have also concluded that disease-causing variants are often clustered in protein-interaction networks with a high degree of connectivity among themselves and that these clustered networks are often enriched with functional pathways relevant to brain functions [72–80].”
From An integrated analysis of genes and functional pathways for aggression in human and rodent models (2019) · cites this paper as [72]
In the citing paper
“These three studies report de novo mutations with a twofold to fourfold increase in de novo nonsense variants among affected subjects over that expected by chance”
From Autism risk factors: genes, environment, and gene-environment interactions (2012) · cites this paper as [36]
In the citing paper
“two of these studies report that spontaneous changes are correlated with paternal age”
From Autism risk factors: genes, environment, and gene-environment interactions (2012) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Self-citationA method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Self-citationFast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,508
Self-citationRare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test
Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,373
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“Copy number variants (CNVs), often de novo and covering multiple adjacent genes, have been identified as conferring risk 3,4 .”
BackgroundSelf-citationGenetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970
Cited by
Sorted by citations
Items 301–400 of 1,004
High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing
Martı́nez, F., Caro‐Llopis, A., Rosello, M., Oltra, S., Mayo, S., Monfort, S., & Orellana, C. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103964 · Cited by 122
Tong, X.-J., Soto, E. J. L., Li, L., Liu, H., Nedelcu, D., Lipscombe, D., Hu, Z., & Kaplan, J. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.018 · Cited by 123
Self-citationNeuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons
Marro, S. G., Chanda, S., Yang, N., Janas, J. A., Valperga, G., Trotter, J. H., Zhou, B., Merrill, S. A., Yousif, I., Shelby, H., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.043 · Cited by 120
Developmental activities of the complement pathway in migrating neurons
Gorelik, A., Sapir, T., Haffner‐Krausz, R., Olender, T., Woodruff, T. M., & Reiner, O. (2017) · Nature Communications · doi:10.1038/ncomms15096 · Cited by 123
Lee, H., Lin, M., Kornblum, H. I., Papazian, D. M., & Nelson, S. F. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu056 · Cited by 119
Transmission Disequilibrium of Small CNVs in Simplex Autism
Krumm, N., O’Roak, B. J., Karakoc, E., Mohajeri, K., Nelson, B., Vives, L., Jacquemont, S., Munson, J., Bernier, R., & Eichler, E. E. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.07.024 · Cited by 113
Interpreting de novo Variation in Human Disease Using denovolyzeR
Ware, J. S., Samocha, K. E., Homsy, J. G., & Daly, M. J. (2015) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0725s87 · Cited by 124
Self-citationIncreased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTor
Oguro-Ando, A., Rosensweig, C., Herman, E., Nishimura, Y., Werling, D., Bill, B. R., Berg, J. M., Gao, F., Coppola, G., Abrahams, B. S., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.124 · Cited by 117
LoFtool: a gene intolerance score based on loss-of-function variants in 60 706 individuals
Fadista, J., Oskolkov, N., Hansson, O., & Groop, L. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv602 · Cited by 114
Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c
Chen, Y.-C., Kuo, H., Bornschein, U., Takahashi, H., Chen, S.-Y., Lu, K.-M., Yang, H.-Y., Chen, G.-M., Lin, J.-R., Lee, Y.-H., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4380 · Cited by 115
Lam, M., Hill, W. D., Trampush, J. W., Yu, J., Knowles, E., Davies, G., Stahl, E. A., Huckins, L. M., Liewald, D. C. M., Djurovic, S., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.06.012 · Cited by 115
Neuronal migration disorders: Focus on the cytoskeleton and epilepsy
Stouffer, M. A., Golden, J. A., & Francis, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.003 · Cited by 123
De novo TBR1 mutations in sporadic autism disrupt protein functions
Deriziotis, P., O’Roak, B. J., Graham, S. A., Estruch, S. B., Dimitropoulou, D., Bernier, R., Gerdts, J. A., Shendure, J., Eichler, E. E., & Fisher, S. E. (2014) · Nature Communications · doi:10.1038/ncomms5954 · Cited by 115
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3
Chao, H., Davids, M., Burke, E. A., Pappas, J., Rosenfeld, J. A., McCarty, A. J., Davis, T., Wolfe, L. A., Toro, C., Tifft, C. J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.018 · Cited by 115
Self-citationMcManus, K. F., Oill, A. M. T., Henn, B. M., Bustamante, C. D., Sikora, M., & Cornejo, O. E. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006560 · Cited by 119
Staahl, B. T., Tang, J., Wu, W., Sun, A. X., Gitler, A. D., Yoo, A. S. J., & Crabtree, G. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1258-13.2013 · Cited by 120
Ness, R. W., Morgan, A. D., Vasanthakrishnan, R. B., Colegrave, N., & Keightley, P. D. (2015) · Genome Research · doi:10.1101/gr.191494.115 · Cited by 117
Petrovski, S., Küry, S., Myers, C. T., Anyane-Yeboa, K., Cogné, B., Bialer, M., Xia, F., Hemati, P., Riviello, J., Mehaffey, M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.011 · Cited by 114
Toma, C., Torrico, B., Hervás, A., Valdés-Mas, R., Tristán-Noguero, A., Padillo, V, Maristany, M., Salgado, M., Arenas, C., Puente, X. S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.106 · Cited by 114
Hou, Q.-L., Wang, Y., Li, Y., Chen, D., Yang, F., & Wang, S. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00182 · Cited by 115
Drosophila melanogaster as a genetic model system to study neurotransmitter transporters
Martin, C. A., & Krantz, D. E. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.03.015 · Cited by 112
Yamada, T., Yang, Y., Hemberg, M., Yoshida, T., Cho, H. Y., Murphy, J. P., Fioravante, D., Regehr, W. G., Gygi, S. P., Georgopoulos, K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.039 · Cited by 116
The FMRP regulon: from targets to disease convergence
Fernández, E., Rajan, N., & Bagni, C. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00191 · Cited by 117
Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders
Poot, M. (2015) · Molecular Syndromology · doi:10.1159/000371594 · Cited by 119
Nava, C., Lamari, F., Héron, D., Mignot, C., Rastetter, A., Keren, B., Cohen, D., Faudet, A., Bouteiller, D., Gilleron, M., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.102 · Cited by 117
Rienhoff, H. Y., Yeo, C., Morissette, R., Khrebtukova, I., Melnick, J. S., Luo, S. J., Leng, N., Kim, Y., Schroth, G. P., Westwick, J. K., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36056 · Cited by 110
The developmental transcriptome of the human brain: implications for neurodevelopmental disorders
Tebbenkamp, A. T. N., Willsey, A. J., State, M. W., & Šestan, N. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000069 · Cited by 110
Drug discovery for autism spectrum disorder: challenges and opportunities
Ghosh, A., Michalon, A., Lindemann, L., Fontoura, P., & Santarelli, L. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4102 · Cited by 108
Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans
Hu, Z., Hom, S., Kudze, T., Tong, X.-J., Choi, S., Aramuni, G., Zhang, W., & Kaplan, J. M. (2012) · Science · doi:10.1126/science.1224896 · Cited by 109
Mutations and Modeling of the Chromatin Remodeler CHD8 Define an Emerging Autism Etiology
Barnard, R., Pomaville, M. B., & O’Roak, B. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00477 · Cited by 111
Werling, D. M., & Geschwind, D. H. (2015) · Molecular Autism · doi:10.1186/s13229-015-0004-5 · Cited by 116
Metabolic Pathology of Autism in Relation to Redox Metabolism
Frye, R. E., & James, S. J. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.158 · Cited by 107
Cappi, C., Oliphant, M. E., Péter, Z., Zai, G. C., do Rosário, M. C., Sullivan, C. A. W., Gupta, A. R., Hoffman, E. J., Virdee, M., Olfson, E., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.029 · Cited by 108
Rovelet-Lecrux, A., Charbonnier, C., Wallon, D., Nicolas, G., Seaman, M. N. J., Pottier, C., Breusegem, S. Y., Mathur, P. P., Jenardhanan, P., Le Guennec, K., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.100 · Cited by 106
Common genetic variants on 1p13.2 associate with risk of autism
Xia, K., Guo, H., Hu, Z., Xun, G., Zuo, L., Peng, Y., Wang, K., He, Y., Xiong, Z., Sun, L., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.146 · Cited by 107
Pugsley, K., Scherer, S. W., Bellgrove, M. A., & Hawi, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01142-w · Cited by 114
Ciernia, A. V., & Wood, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.002 · Cited by 108
Mosaic Epigenetic Dysregulation of Ectodermal Cells in Autism Spectrum Disorder
Berko, E. R., Suzuki, M., Beren, F., Lemetre, C., Alaimo, C. M., Calder, R. B., Ballaban‐Gil, K. R., Gounder, B., Kampf, K., Kirschen, J., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004402 · Cited by 110
Self-citationFrom Maternal Diet to Neurodevelopmental Disorders: A Story of Neuroinflammation
Bordeleau, M., de Cossío, L. F., Chakravarty, M. M., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.612705 · Cited by 110
Wilkinson, B., Grepo, N., Thompson, B. L., Kim, J. Y., Wang, K., Evgrafov, O. V., Lu, W., Knowles, J. A., & Campbell, D. B. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.62 · Cited by 101
Kataoka, M., Matoba, N., Sawada, T., Kazuno, A.-A., Ishiwata, M., Fujii, K., Matsuo, K., Takata, A., & Kato, T. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.69 · Cited by 104
Autism risk in offspring can be assessed through quantification of male sperm mosaicism
Breuss, M. W., Antaki, D., George, R. D., Kleiber, M. L., James, K. N., Ball, L., Hong, O., Mitra, I., Yang, X., Wirth, S. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0711-0 · Cited by 107
ERK/MAPK signaling and autism spectrum disorders
Vithayathil, J., Pucilowska, J., & Landreth, G. E. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.09.008 · Cited by 104
Crabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 106
Nattel, S. N., Adrianzen, L., Kessler, E. C., Andelfinger, G., Dehaes, M., Côté‐Corriveau, G., & Trelles, M. P. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.09.020 · Cited by 107
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development
Podolskiy, D. I., Lobanov, A. V., Kryukov, G. V., & Gladyshev, V. N. (2016) · Nature Communications · doi:10.1038/ncomms12157 · Cited by 100
CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures
Thomas, R. H., Zhang, L. M., Carvill, G. L., Archer, J. S., Heavin, S. B., Mandelstam, S. A., Craiu, D., Berkovic, S. F., Gill, D. S., Mefford, H. C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001305 · Cited by 100
The genetics of cognitive epigenetics
Kleefstra, T., Schenck, A., Kramer, J. M., & van Bokhoven, H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.025 · Cited by 114
Li, J., Wang, L., Guo, H., Shi, L., Zhang, K., Tang, M., Hu, S., Dong, S., Liu, Y., Wang, T., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.140 · Cited by 101
Self-citationThe neurobiology of autism spectrum disorders
Parellada, M., Penzol, M. J., Pina‐Camacho, L., Moreno, C., González‐Vioque, E., Zalsman, G., & Arango, C. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.02.005 · Cited by 115
Network-assisted analysis to prioritize GWAS results: principles, methods and perspectives
Jia, P., & Zhao, Z. (2013) · Human Genetics · doi:10.1007/s00439-013-1377-1 · Cited by 99
Klein, M., Onnink, A. M. H., van Eijk, K. R., Wolfers, T., Harich, B., Shi, Y., Dammers, J. T., Vásquez, A. A., Hoogman, M., & Franke, B. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.013 · Cited by 116
Correction: Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes
Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S., & Goldstein, D. B. (2013) · PLoS Genetics · doi:10.1371/annotation/32c8d343-9e1d-46c6-bfd4-b0cd3fb7a97e · Cited by 100
Ku, C., Polychronakos, C., Tan, E., Naidoo, N., Yudi Pawitan, Y., Roukos, D. H., Mort, M. E., & Cooper, D. N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.58 · Cited by 99
POGZ truncating alleles cause syndromic intellectual disability
White, J. J., Beck, C. R., Harel, T., Posey, J. E., Jhangiani, S. N., Tang, S., Hagman, K. D. F., Powis, Z., Mendelsohn, N. J., Baker, J. A., et al. (2016) · Genome Medicine · doi:10.1186/s13073-015-0253-0 · Cited by 100
Self-citationPaternal age and psychiatric disorders: A review
de Kluiver, H., Buizer‐Voskamp, J. E., Dolan, C. V., & Boomsma, D. I. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32508 · Cited by 102
Al-Mubarak, B. R., Abouelhoda, M. I., Omar, A., Aldhalaan, H., Aldosari, M., Nester, M. J., Al-Shamrani, H., El-Kalioby, M., Goljan, E., Albar, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06033-1 · Cited by 99
Willsey, H. R., Exner, C. R. T., Xu, Y., Everitt, A., Sun, N., Wang, B., Dea, J., Schmunk, G., Zaltsman, Y., Teerikorpi, N., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.002 · Cited by 98
De novo variants in sporadic cases of childhood onset schizophrenia
Ambalavanan, A., Girard, S., Ahn, K., Zhou, S., Dionne‐Laporte, A., Spiegelman, D., Bourassa, C. V., Gauthier, J., Hamdan, F. F., Xiong, L., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.218 · Cited by 98
A Bayesian framework for de novo mutation calling in parents-offspring trios
Wei, Q., Zhan, X., Zhong, X. Y., Liu, Y., Han, Y., Chen, W., & Li, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu839 · Cited by 92
Self-citationAn integrated analysis of genes and functional pathways for aggression in human and rodent models
Zhang-James, Y., Fernàndez-Castillo, N., Hess, J. L., Malki, K., Glatt, S. J., Cormand, B., & Faraone, S. V. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0068-7 · Cited by 98
Frye, R. E., & Rossignol, D. A. (2016) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s38337 · Cited by 96
The genomics of schizophrenia: update and implications
Giusti‐Rodríguez, P., & Sullivan, P. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66031 · Cited by 99
Simonis, N., Migeotte, I., Lambert, N., Perazzolo, C., de Silva, D. D., Dimitrov, B., Heinrichs, C., Janssens, S., Kerr, B., Mortier, G., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101603 · Cited by 89
Whole Exome Sequencing in Females with Autism Implicates Novel and Candidate Genes
Butler, M. G., Rafi, S. K., Hossain, W. A., Stephan, D. A., & Manzardo, A. M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011312 · Cited by 93
Immune-mediated disease genetics: the shared basis of pathogenesis
Cotsapas, C., & Hafler, D. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.09.001 · Cited by 109
Genomic and genetic aspects of autism spectrum disorder
Liu, X., & Takumi, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.108 · Cited by 95
Sowers, L. P., Loo, L., Wu, Y. C., Campbell, E., Ulrich, J. D., Wu, S., Paemka, L., Wassink, T. H., Meyer, K. J., Bing, X., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.71 · Cited by 95
Self-citationChénier, S., Yoon, G., Argiropoulos, B., Lauzon, J. L., Laframboise, R., Ahn, J. W., Ogilvie, C. M., Lionel, A. C., Marshall, C. R., Vaags, A. K., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-9 · Cited by 99
Questions about DISC1 as a genetic risk factor for schizophrenia
Sullivan, P. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.182 · Cited by 93
Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder
Hashimoto, R., Nakazawa, T., Tsurusaki, Y., Yasuda, Y., Nagayasu, K., Matsumura, K., Kawashima, H., Yamamori, H., Fujimoto, M., Ohi, K., et al. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.141 · Cited by 95
Excessive D1 Dopamine Receptor Activation in the Dorsal Striatum Promotes Autistic-Like Behaviors
Lee, Y., Kim, H., Kim, J., Park, J. Y., Choi, J., Lee, J. E., Lee, E. H., & Han, P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0770-5 · Cited by 89
Al-Naama, N., Mackeh, R., & Kino, T. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00032 · Cited by 92
Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes
Guipponi, M., Santoni, F. A., Setola, V., Gehrig, C., Rothärmel, M., Cuenca, M., Guillin, O., Dikeos, D. G., Georgantopoulos, G., Papadimitriou, G. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112745 · Cited by 92
RELN Mutations in Autism Spectrum Disorder
Lammert, D. B., & Howell, B. W. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00084 · Cited by 97
The Genetics of Autism Spectrum Disorders
Huguet, G., Benabou, M., & Bourgeron, T. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-27069-2_11 · Cited by 105
Li, M., Kwan, J. S. H., & Sham, P. C. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.004 · Cited by 93
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons
Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 97
Pagel, K. A., Pejaver, V. R., Lin, G. N., Nam, H.-J., Mort, M. E., Cooper, D. N., Sebat, J. L., Iakoucheva, L. M., Mooney, S. D., & Predrag Radivojac, A. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx272 · Cited by 90
Kasture, A. S., Hummel, T., Sučić, S., & Freissmuth, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061788 · Cited by 99
Delling, J. P., & Boeckers, T. M. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09397-8 · Cited by 104
Support for calcium channel gene defects in autism spectrum disorders
Lu, A. T.-H., Dai, X., Martínez-Agosto, J. A., & Cantor, R. M. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-18 · Cited by 100
Autism-associated CHD8 deficiency impairs axon development and migration of cortical neurons
Xu, Q., Liu, Y.-Y., Wang, X., Tan, G., Li, H., Hulbert, S. W., Li, C., Hu, C.-C., Xiong, Z., Xu, X., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0244-2 · Cited by 92
Orosco, L. A., Ross, A. P., Cates, S. L., Scott, S. E., Wu, D., Sohn, J., Pleasure, D., Pleasure, S. J., Adamopoulos, I. E., & Zarbalis, K. S. (2014) · Nature Communications · doi:10.1038/ncomms5692 · Cited by 90
Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
Frye, R. E., & Rossignol, D. A. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00066 · Cited by 90
Autism spectrum disorders and coexisting disorders in a nationwide Swedish twin study
Lundström, S., Reichenberg, A., Melke, J., Råstam, M., Kerekes, N., Lichtenstein, P., Gillberg, C., & Anckarsäter, H. S. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12329 · Cited by 102
Dougherty, J. D., Maloney, S. E., Wozniak, D. F., Rieger, M. A., Sonnenblick, L. I., Coppola, G., Mahieu, N. G., Zhang, J., Cai, J., Patti, G. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4762-12.2013 · Cited by 88
Revitalizing Psychiatric Therapeutics
Hyman, S. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.181 · Cited by 92
Hu, V. W., Sarachana, T., Sherrard, R. M., & Kocher, K. M. (2015) · Molecular Autism · doi:10.1186/2040-2392-6-7 · Cited by 93
Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology
McCarroll, S. A., & Hyman, S. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.046 · Cited by 90
Ionita‐Laza, I., Lee, S., Makarov, V., Buxbaum, J. D., & Lin, X. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.308 · Cited by 87
Self-citationBerecki, G., Howell, K. B., Deerasooriya, Y. H., Cilio, M. R., Oliva, M., Kaplan, D. I., Scheffer, I. E., Berkovic, S. F., & Petrou, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800077115 · Cited by 85
Pollack, S. J., Igo, R. P., Jensen, R. A., Christiansen, M. W., Li, X., Cheng, C., Ng, M. C. Y., Smith, A. V., Rossin, E. J., Segrè, A. V., et al. (2018) · Diabetes · doi:10.2337/db18-0567 · Cited by 86
Self-citationElmer, B. M., Estes, M. L., Barrow, S. L., & McAllister, A. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2366-13.2013 · Cited by 88
The protomap is propagated to cortical plate neurons through an Eomes -dependent intermediate map
Elsen, G. E., Hodge, R. D., Bedogni, F., Daza, R. A. M., Nelson, B. R., Shiba, N., Reiner, S. L., & Hevner, R. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209076110 · Cited by 87
Schizophrenia genetics: emerging themes for a complex disorder
Kavanagh, D. H., Tansey, K. E., O’Donovan, M. C., & Owen, M. J. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.148 · Cited by 93
Genome-scale neurogenetics: methodology and meaning
McCarroll, S. A., Feng, G., & Hyman, S. E. (2014) · Nature Neuroscience · doi:10.1038/nn.3716 · Cited by 89
Pratt, K. G., & Khakhalin, A. S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012138 · Cited by 94
Essential genetic findings in neurodevelopmental disorders
Cardoso, A. R., Lopes‐Marques, M., Silva, R. M., Serrano, C., Amorim, A., Prata, M. J., & Azevedo, L. (2019) · Human Genomics · doi:10.1186/s40246-019-0216-4 · Cited by 99
Modafferi, S., Zhong, X., Kleensang, A., Murata, Y., Fagiani, F., Pamies, D., Högberg, H. T., Calabrese, V., Lachman, H. M., Härtung, T., et al. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8580 · Cited by 91
Metadata
- Authors
- Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., Polak, P., Yoon, S., Maguire, J., Crawford, E. L., Campbell, N. G., Geller, E. T., Valladares, O., Schafer, C., Liu, H., Zhao, T., Cai, G., Lihm, J., Dannenfelser, R., Jabado, O., Peralta, Z., Nagaswamy, U., Muzny, D., Reid, J. G., Newsham, I., Wu, Y., Lewis, L., Han, Y., Voight, B. F., Lim, E., Rossin, E., Kirby, A., Flannick, J., Fromer, M., Shakir, K., Fennell, T., Garimella, K., Banks, E., Poplin, R., Gabriel, S., DePristo, M., Wimbish, J. R., Boone, B. E., Levy, S. E., Betancur, C., Sunyaev, S., Boerwinkle, E., Buxbaum, J. D., Cook Jr, E. H., Devlin, B., Gibbs, R. A., Roeder, K., Schellenberg, G. D., Sutcliffe, J. S., & Daly, M. J.
- Affiliations
- Harvard University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Carnegie Mellon University (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- University of Pennsylvania (US)
- Vanderbilt University (US)
- Johns Hopkins University (US)
- HudsonAlpha Institute for Biotechnology (US)
- Centre National de la Recherche Scientifique (FR)
- University of Pittsburgh (US)
- Corresponding author
- Buxbaum, Joseph D.
- Roeder, Kathryn
- Daly, Mark J.
- ORCID
- Neale, Benjamin M.
- Liu, Li
- Ma’ayan, Avi
- Samocha, Kaitlin E.
- Sabo, Aniko
- Lin, Chiao-Feng
- Stevens, Christine
- Makarov, Vladimir
- Polak, Paz
- Geller, Evan T.
- Valladares, Otto
- Liu, Han
- Zhao, Tuo
- Lihm, Jayon
- Dannenfelser, Ruth
- Muzny, Donna
- Reid, Jeffrey G.
- Newsham, Irene
- Wu, Yuanqing
- Han, Yi
- Voight, Benjamin F.
- Lim, Elaine
- Rossin, Elizabeth
- Flannick, Jason
- Fromer, Menachem
- Fennell, Tim
- Garimella, Kiran
- Banks, Eric
- Gabriel, Stacey
- Levy, Shawn E.
- Betancur, Catalina
- Sunyaev, Shamil
- Boerwinkle, Eric
- Buxbaum, Joseph D.
- Devlin, Bernie
- Gibbs, Richard A.
- Roeder, Kathryn
- Schellenberg, Gerard D.
- Sutcliffe, James S.
- Daly, Mark J.
- Venue
- Nature
- Published
- 2012-04-04
- Volume
- 485
- Issue
- 7397
- Pages
- 242-245
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3613847
- OpenAlex
- W2024663595
- Semantic Scholar
- 7597cd398ad2874b3c231d70f97956fb53b1be57
- Cited by
- 1,734
- References
- 27
- Citations by year
- 2026: 32 · 2025: 44 · 2024: 56 · 2023: 56 · 2022: 75 · 2021: 99 · 2020: 110 · 2019: 121 · 2018: 125 · 2017: 144 · 2016: 158 · 2015: 180 · 2014: 245 · 2013: 194 · 2012: 92
- FWCI
- 116.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Vanderbilt University (UL1 RR024975)
- National Institutes of Health (MH057881, HD015052, HD055751, RR024975)
- Vanderbilt Kennedy Center, Vanderbilt University Medical Center
- National Institute of Mental Health (R01MH061009, R01MH089025, R01MH089175, R01MH089004, R01MH089208, R01MH057881, MH057881, R01MH089482, R01MH084676)
- National Human Genome Research Institute (U54HG003067, HG003273, U54HG003273)
- National Institute of General Medical Sciences (T32GM007753, P50GM071558)
- National Center for Research Resources (RR024975, KL2RR024977, TL1RR024978, UL1RR024975)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052, P50HD055751)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- autism spectrum disorder, genetic heterogeneity, locus heterogeneity, polygenic risk, parent-child trios, exome sequencing, protein-protein interaction network, SCN2A, CHD8, β-catenin signaling, p53 pathway, mutation rate, penetrance, copy number variation, genetic risk
- MeSH terms
- Autistic Disorder, DNA-Binding Proteins, Exons, Family Health, Humans, Models, Genetic, Mutation, Phenotype, Transcription Factors, Poisson Distribution, Case-Control Studies, Genetic Predisposition to Disease, Multifactorial Inheritance, Exome, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
